why choose us

First received: January 20, 2023

Clinical Trial: Aflo™ Device Trial

Study Status: Completed

Recruit Status: RECRUITING

Condition: Asthma

Study Type: INTERVENTIONAL


Official Title: Automating Patient Inhaler Technique When Using Pressurised Metered Dose Inhalers: Testing the Functionality and Impact of the Aflo™ Digital Respiratory Management Platform in a Randomised Controlled

Brief Summary: This randomised, prospective, controlled parallel study aims to evaluate the role and potential of the aflo™ digital platform for improving asthma control, inhalation technique and adherence in patients who use metred dose inhalers (MDI).The study will recruit 104 patients with uncontrolled asthma in the North-West of Northern Ireland.Fifty two patients will remain on standard care over 24-weeks and 52 will combine standard care with the aflo™ platform.The data collected over a 24-week period will be used to…

Read more